Cargando…

Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series

OBJECTIVE: To assess the perioperative morbidity of transvesical open prostatectomy (OP) and its predictors as a treatment for benign prostatic hyperplasia (BPH), and to update knowledge about the morbidity of OP using a standardised morbidity scale (Clavien), thus providing a platform for compariso...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshal, Ahmed M., El-Nahas, Ahmed R., Barakat, Tamer S., Elsaadany, Mohamed M., El-Hefnawy, Ahmed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442976/
https://www.ncbi.nlm.nih.gov/pubmed/26558107
http://dx.doi.org/10.1016/j.aju.2013.06.003
_version_ 1782372954830536704
author Elshal, Ahmed M.
El-Nahas, Ahmed R.
Barakat, Tamer S.
Elsaadany, Mohamed M.
El-Hefnawy, Ahmed S.
author_facet Elshal, Ahmed M.
El-Nahas, Ahmed R.
Barakat, Tamer S.
Elsaadany, Mohamed M.
El-Hefnawy, Ahmed S.
author_sort Elshal, Ahmed M.
collection PubMed
description OBJECTIVE: To assess the perioperative morbidity of transvesical open prostatectomy (OP) and its predictors as a treatment for benign prostatic hyperplasia (BPH), and to update knowledge about the morbidity of OP using a standardised morbidity scale (Clavien), thus providing a platform for comparison with the newly developed techniques. PATIENTS AND METHODS: We retrospectively review men with BPH who were treated with transvesical OP between April 2002 and December 2012. Preoperative patients’ data were reviewed for relevant variables. Operative details, the postoperative course, and 30-day relevant data were assessed. The study cohort was stratified based on the resected prostate weight, with group 1 having a resected weight of ⩽120 g and group 2 >120 g. RESULTS: The review identified 163 patients. The mean (SD, range) duration of catheterisation after OP was 7.9 (2.2, 5–20) days and the duration of hospitalisation after OP was 8.1 (1.8, 5–15) days; both were significantly longer in group 2. All patients were able to void spontaneously by the first follow-up visit. Of 163 OP procedures, there were 106 perioperative complications in 69 (42.3%). Low-grade complications (grade ⩽2) included 38 (45.2%) and 53 (67%) in groups 1 and 2, respectively (P = 0.8). High-grade complications (⩾3) included 3 (3.5%) and 12 (15.1%) in groups 1 and 2, respectively (P = 0.02). The blood transfusion rate was 24.5%, the perioperative mortality rate was 1.2% and the re-admission rate within the first 30 days after OP was 1.2%. High-grade complications were significantly associated with a greater resected prostate weight (odds ratio 1.08, 95% CI 1.001–1.17, P = 0.046). CONCLUSION: The OP procedure is associated with a significant perioperative morbidity that correlated significantly with the resected prostate weight, especially for high-grade complications.
format Online
Article
Text
id pubmed-4442976
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44429762015-11-10 Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series Elshal, Ahmed M. El-Nahas, Ahmed R. Barakat, Tamer S. Elsaadany, Mohamed M. El-Hefnawy, Ahmed S. Arab J Urol Oncology / Reconstruction Original Article OBJECTIVE: To assess the perioperative morbidity of transvesical open prostatectomy (OP) and its predictors as a treatment for benign prostatic hyperplasia (BPH), and to update knowledge about the morbidity of OP using a standardised morbidity scale (Clavien), thus providing a platform for comparison with the newly developed techniques. PATIENTS AND METHODS: We retrospectively review men with BPH who were treated with transvesical OP between April 2002 and December 2012. Preoperative patients’ data were reviewed for relevant variables. Operative details, the postoperative course, and 30-day relevant data were assessed. The study cohort was stratified based on the resected prostate weight, with group 1 having a resected weight of ⩽120 g and group 2 >120 g. RESULTS: The review identified 163 patients. The mean (SD, range) duration of catheterisation after OP was 7.9 (2.2, 5–20) days and the duration of hospitalisation after OP was 8.1 (1.8, 5–15) days; both were significantly longer in group 2. All patients were able to void spontaneously by the first follow-up visit. Of 163 OP procedures, there were 106 perioperative complications in 69 (42.3%). Low-grade complications (grade ⩽2) included 38 (45.2%) and 53 (67%) in groups 1 and 2, respectively (P = 0.8). High-grade complications (⩾3) included 3 (3.5%) and 12 (15.1%) in groups 1 and 2, respectively (P = 0.02). The blood transfusion rate was 24.5%, the perioperative mortality rate was 1.2% and the re-admission rate within the first 30 days after OP was 1.2%. High-grade complications were significantly associated with a greater resected prostate weight (odds ratio 1.08, 95% CI 1.001–1.17, P = 0.046). CONCLUSION: The OP procedure is associated with a significant perioperative morbidity that correlated significantly with the resected prostate weight, especially for high-grade complications. Elsevier 2013-12 2013-07-31 /pmc/articles/PMC4442976/ /pubmed/26558107 http://dx.doi.org/10.1016/j.aju.2013.06.003 Text en © 2013 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Oncology / Reconstruction Original Article
Elshal, Ahmed M.
El-Nahas, Ahmed R.
Barakat, Tamer S.
Elsaadany, Mohamed M.
El-Hefnawy, Ahmed S.
Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title_full Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title_fullStr Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title_full_unstemmed Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title_short Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: Perioperative outcomes of a contemporary series
title_sort transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: perioperative outcomes of a contemporary series
topic Oncology / Reconstruction Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442976/
https://www.ncbi.nlm.nih.gov/pubmed/26558107
http://dx.doi.org/10.1016/j.aju.2013.06.003
work_keys_str_mv AT elshalahmedm transvesicalopenprostatectomyforbenignprostatichyperplasiaintheeraofminimallyinvasivesurgeryperioperativeoutcomesofacontemporaryseries
AT elnahasahmedr transvesicalopenprostatectomyforbenignprostatichyperplasiaintheeraofminimallyinvasivesurgeryperioperativeoutcomesofacontemporaryseries
AT barakattamers transvesicalopenprostatectomyforbenignprostatichyperplasiaintheeraofminimallyinvasivesurgeryperioperativeoutcomesofacontemporaryseries
AT elsaadanymohamedm transvesicalopenprostatectomyforbenignprostatichyperplasiaintheeraofminimallyinvasivesurgeryperioperativeoutcomesofacontemporaryseries
AT elhefnawyahmeds transvesicalopenprostatectomyforbenignprostatichyperplasiaintheeraofminimallyinvasivesurgeryperioperativeoutcomesofacontemporaryseries